Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: Gains of the chromosomal segment 3q26q29 as an adverse risk factor

Blood

Volumn 101, Issue 10, 2003, Pages 3872-3874

  Tönnies, Holger ^b   Huber, Stefanie ^b   Kühl, Jörn Sven ^b   Gerlach, Antje ^b   Ebell, Wolfram ^b   Neitzel, Heidemarie ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BONE MARROW CELL; CHILD; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TETRASOMY; TRISOMY; BONE MARROW; CHROMOSOME 3; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY;

ADULT; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; FANCONI ANEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RISK FACTORS;

EID: 0038603848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3243     Document Type: Article

References (18)

1. Futaki M, Liu JM. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med. 2001;7:560-565.
2. Grompe M, D'Andrea A. Fanconi anemia and DNA repair. Hum Mol Genet. 2001;10:2253-2259.
3. Donahue SL, Campbell C. A DNA double strand break repair defect in Fanconi anemia fibroblasts. J Biol Chem. 2002;277:46243-46247.
4. Taniguchi T, Dandrea AD. Molecular pathogenesis of Fanconi anemia. Int J Hematol. 2002;75: 123-128.
5. Folias A, Matkovic M, Bruun D, et al. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum Mol Genet. 2002;11:2591-2597.
6. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110.
7. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet. 2000;117:125-131.
8. Berger R, Le Coniat M, Schaison G. Chromosome abnormalities in bone marrow of Fanconi anemia patients. Cancer Genet Cytogenet. 1993; 65:47-50.
9. Maarek O, Jonveaux P, Le Coniat M, Derre J, Berger R. Fanconi anemia and bone marrow clonal chromosome abnormalities. Leukemia. 1996;10:1700-1704.
10. Tönnies H, Stumm M, Wegner RD, Chudoba I, Kalscheuer V, Neitzel H. Comparative genomic hybridization based strategy for the analysis of different chromosome imbalances detected in conventional cytogenetic diagnostics. Cytogenet Cell Genet. 2001;93:188-194.
11. Tónnies H. Modern molecular cytogenetic techniques in genetic diagnostics. Trends Mol Med. 2002;8:246-250.
12. Berger R, Bussel A, Schenmetzler C. Somatic segregation and Fanconi anemia. Clin Genet. 1977;11:409-412.
13. Berger R, Bernheim A, Le Coniat M, Vecchione D, Schaison G. Chromosomal studies of leukemic and preleukemic Fanconi's anemia patients: examples of acquired 'chromosomal amplification.' Hum Genet. 1980;56:59-62.
14. Yoneda-Kato N, Look AT, Kirstein MN, et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene. 1996;12: 265-275.
15. Morishita K, Parganas E, Willman CL, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Nat Acad Sci. 1992;89: 3937-3941.
16. Ogawa S, Kurokawa M, Tanaka T, et al. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene. 1996;13:183-191.
17. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 1995;86:1-14.
18. Testoni N, Borsaru G, Martinelli G, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica. 1999;84:690-694.